FTC sues significant pharmacy gain professionals over insulin selling prices The agency introduced motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of lifetime-preserving insulin prescription drugs. Where are every one of the nurses? Hospitals, advocates disagree on crisis https://ayahealthcareaddress97530.mybuzzblog.com/10240115/the-healthcare-news-diaries